Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337

1.

An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.

Bai Y, Xu J, Brahimi F, Zhuo Y, Sarunic MV, Saragovi HU.

Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4722-31. doi: 10.1167/iovs.09-5032. Epub 2010 Mar 31.

PMID:
20357199
2.

Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.

Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ.

Invest Ophthalmol Vis Sci. 2000 Mar;41(3):764-74.

PMID:
10711692
3.

Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.

Fu QL, Li X, Yip HK, Shao Z, Wu W, Mi S, So KF.

Neuroscience. 2009 Aug 18;162(2):375-82. doi: 10.1016/j.neuroscience.2009.04.075. Epub 2009 May 5.

PMID:
19422885
4.
5.

Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.

Hu Y, Cho S, Goldberg JL.

Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1747-54. doi: 10.1167/iovs.09-4450. Epub 2009 Oct 29.

6.

Changes in brain-derived neurotrophic factor and trkB receptor in the adult Rana pipiens retina and optic tectum after optic nerve injury.

Duprey-Díaz MV, Soto I, Blagburn JM, Blanco RE.

J Comp Neurol. 2002 Dec 23;454(4):456-69.

PMID:
12455009
7.

Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS.

Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1212-8.

PMID:
17325165
8.

Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.

Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1437-46. doi: 10.1167/iovs.07-1337.

PMID:
18385061
9.
10.

Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model.

Martin KR, Quigley HA, Zack DJ, Levkovitch-Verbin H, Kielczewski J, Valenta D, Baumrind L, Pease ME, Klein RL, Hauswirth WW.

Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65.

PMID:
14507880
11.

Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.

Weishaupt JH, Rohde G, Pölking E, Siren AL, Ehrenreich H, Bähr M.

Invest Ophthalmol Vis Sci. 2004 May;45(5):1514-22.

PMID:
15111610
13.
14.
15.

Expression of trkA, trkB, and trkC in injured and regenerating retinal ganglion cells of adult rats.

Cui Q, Tang LS, Hu B, So KF, Yip HK.

Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1954-64.

PMID:
12037005
16.

TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo.

Cheng L, Sapieha P, Kittlerova P, Hauswirth WW, Di Polo A.

J Neurosci. 2002 May 15;22(10):3977-86.

18.

Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture.

Fischer D, Pavlidis M, Thanos S.

Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3943-54.

PMID:
11053298
19.

Neurotrophic rationale in glaucoma: a TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo.

Shi Z, Birman E, Saragovi HU.

Dev Neurobiol. 2007 Jun;67(7):884-94. Erratum in: Dev Neurobiol. 2007 Sep 15;67(11):1547-8.

Supplemental Content

Support Center